PA
ABBV icon

Promethium Advisors’s AbbVie ABBV Stock Holding History

Promethium Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.83M Hold
17,605
– – 1.98% 13
2025
Q4 		$4.02M Sell
17,605
-62
-0.4% -$14.1K 2.17% 10
2025
Q3 		$4.09M Sell
17,667
-236
-1% -$48.1K 2.35% 9
2025
Q2 		$3.32M Buy
17,903
+74
+0.4% +$13.8K 2.02% 13
2025
Q1 		$3.74M Buy
17,829
+1,050
+6% +$204K 2.39% 9
2024
Q4 		$2.98M Buy
16,779
+1,168
+7% +$215K 2.04% 11
2024
Q3 		$3.08M Buy
+15,611
New +$2.91M 2.18% 11

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Promethium Advisors's ABBV Position: Q1 2026 in Review

Promethium Advisors held its AbbVie (ABBV) position steady in Q1 2026 at 17,605 shares worth $3.83M. The position accounts for 1.98% of the portfolio, ranked #13.

Promethium Advisors first reported a position in ABBV in Q3 2024 and has held it in 7 quarters since. The position peaked at $4.09M in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Promethium Advisors held 17,605 shares of AbbVie worth $3.83M as of Q1 2026.
  • Promethium Advisors left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 1.98% of Promethium Advisors's portfolio in Q1 2026, its #13 holding.
  • Promethium Advisors first reported a position in AbbVie in Q3 2024 and has held it in 7 quarters since.
  • Promethium Advisors's AbbVie position peaked at $4.09M in Q3 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Promethium Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.